Cell-Permeating α-Ketoglutarate Derivatives Alleviate Pseudohypoxia in Succinate Dehydrogenase-Deficient Cells

ABSTRACT Succinate dehydrogenase (SDH) and fumarate hydratase (FH) are components of the tricarboxylic acid (TCA) cycle and tumor suppressors. Loss of SDH or FH induces pseudohypoxia, a major tumor-supporting event, which is the activation of hypoxia-inducible factor (HIF) under normoxia. In SDH- or FH-deficient cells, HIF activation is due to HIF1α stabilization by succinate or fumarate, respectively, either of which, when in excess, inhibits HIFα prolyl hydroxylase (PHD). To reactivate PHD, we focused on its substrate, α-ketoglutarate. We designed and synthesized cell-permeating α-ketoglutarate derivatives, which build up rapidly and preferentially in cells with a dysfunctional TCA cycle. This study shows that succinate- or fumarate-mediated inhibition of PHD is competitive and is reversed by pharmacologically elevating intracellular α-ketoglutarate. Introduction of α-ketoglutarate derivatives restores normal PHD activity and HIF1α levels to SDH-suppressed cells, indicating new therapy possibilities for the cancers associated with TCA cycle dysfunction.

[1]  J. Pincemail,et al.  [Oxidative stress]. , 2007, Revue medicale de Liege.

[2]  E. Gottlieb,et al.  Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.

[3]  Brian J. Smith,et al.  Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability. , 2006, Cancer research.

[4]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[5]  E. Gottlieb,et al.  Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells. , 2006, Biochimica et biophysica acta.

[6]  Kristiina Aittomäki,et al.  Distinct expression profile in fumarate-hydratase-deficient uterine fibroids. , 2006, Human molecular genetics.

[7]  Eyal Gottlieb,et al.  Mitochondrial tumour suppressors: a genetic and biochemical update , 2005, Nature Reviews Cancer.

[8]  W. Kaelin,et al.  Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. , 2005, Cancer cell.

[9]  J R Griffiths,et al.  Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.

[10]  Sandro Santagata,et al.  A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas , 2005, PLoS genetics.

[11]  Yuen-Li Chung,et al.  HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. , 2005, Cancer cell.

[12]  R. Poulsom,et al.  Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome , 2005, The Journal of pathology.

[13]  Okio Hino,et al.  A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. , 2005, Cancer research.

[14]  Eyal Gottlieb,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[15]  David G. Watson,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[16]  W. Kaelin,et al.  Role of VHL gene mutation in human cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Fatima Mechta-Grigoriou,et al.  JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress , 2004, Cell.

[18]  Christopher J. Schofield,et al.  Oxygen sensing by HIF hydroxylases , 2004, Nature Reviews Molecular Cell Biology.

[19]  M. Simon,et al.  HIFs, hypoxia, and vascular development. , 2004, Current topics in developmental biology.

[20]  K. Kivirikko,et al.  Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor* , 2003, Journal of Biological Chemistry.

[21]  S. Grimm,et al.  The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. , 2003, Molecular biology of the cell.

[22]  C. Aston,et al.  Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect , 2003, Human Genetics.

[23]  W. Kaelin,et al.  HIF hydroxylation and the mammalian oxygen-sensing pathway. , 2003, The Journal of clinical investigation.

[24]  S. Iwata,et al.  Architecture of Succinate Dehydrogenase and Reactive Oxygen Species Generation , 2003, Science.

[25]  Kevin R. Messner,et al.  Mechanism of Superoxide and Hydrogen Peroxide Formation by Fumarate Reductase, Succinate Dehydrogenase, and Aspartate Oxidase* , 2002, The Journal of Biological Chemistry.

[26]  Jianhe Huang,et al.  Sequence Determinants in Hypoxia-inducible Factor-1α for Hydroxylation by the Prolyl Hydroxylases PHD1, PHD2, and PHD3* , 2002, The Journal of Biological Chemistry.

[27]  P. Rustin,et al.  Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. , 2002, The Journal of clinical endocrinology and metabolism.

[28]  G. Semenza,et al.  HIF-1 and tumor progression: pathophysiology and therapeutics. , 2002, Trends in molecular medicine.

[29]  P. Rustin,et al.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.

[30]  Y. Yoshikawa,et al.  Synthesis and siderophore activity of vibrioferrin and one of its diastereomeric isomers , 1999 .

[31]  J. Domagala.  A mild, rapid, and convenient esterification of α-keto acids , 1980 .

[32]  B. Corkey,et al.  Assay of citric acid cycle intermediates and related compounds--update with tissue metabolite levels and intracellular distribution. , 1979, Methods in enzymology.